1. Home
  2. PRAX vs WTFC Comparison

PRAX vs WTFC Comparison

Compare PRAX & WTFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$344.19

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Logo Wintrust Financial Corporation

WTFC

Wintrust Financial Corporation

HOLD

Current Price

$149.85

Market Cap

9.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
WTFC
Founded
2015
1991
Country
United States
United States
Employees
N/A
5902
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRAX
WTFC
Price
$344.19
$149.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
14
Target Price
$572.13
$168.07
AVG Volume (30 Days)
332.8K
362.3K
Earning Date
05-08-2026
04-20-2026
Dividend Yield
N/A
1.49%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.96
Revenue Next Year
$7,758.26
$6.54
P/E Ratio
N/A
$13.60
Revenue Growth
N/A
N/A
52 Week Low
$35.21
$116.74
52 Week High
$358.76
$162.96

Technical Indicators

Market Signals
Indicator
PRAX
WTFC
Relative Strength Index (RSI) 55.46 54.97
Support Level $282.49 $142.00
Resistance Level $353.86 $155.41
Average True Range (ATR) 20.50 3.03
MACD 0.17 -0.25
Stochastic Oscillator 71.68 58.73

Price Performance

Historical Comparison
PRAX
WTFC

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About WTFC Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. Its operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

Share on Social Networks: